For help on how to get the results you want, see our search tips.
2031 results
-
List item
Human medicine European public assessment report (EPAR): Colobreathe (updated)
Colistimethate sodium, Cystic Fibrosis
Date of authorisation: 13/02/2012, Revision: 16, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Vantavo (previously Alendronate sodium and colecalciferol, MSD) (updated)
alendronic acid, colecalciferol, Osteoporosis, Postmenopausal
Date of authorisation: 16/10/2009, Revision: 18, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Gazyvaro (updated)
Obinutuzumab, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 22/07/2014,
, 
, Revision: 15, Withdrawn, Last updated: 04/10/2023
-
List item
Human medicine European public assessment report (EPAR): Fosavance (updated)
alendronic acid, colecalciferol, Osteoporosis, Postmenopausal
Date of authorisation: 24/08/2005, Revision: 27, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Cholib (updated)
fenofibrate, simvastatin, Dyslipidemias
Date of authorisation: 26/08/2013, Revision: 16, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Zarzio (updated)
filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 06/02/2009,
, Revision: 24, Authorised, Last updated: 04/10/2023
-
List item
Human medicine European public assessment report (EPAR): Adrovance (updated)
colecalciferol, alendronic acid (as sodium trihydrate), Osteoporosis, Postmenopausal
Date of authorisation: 04/01/2007, Revision: 25, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Trixeo Aerosphere (updated)
formoterol fumarate dihydrate, Glycopyrronium bromide, Budesonide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 09/12/2020, Revision: 4, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Ovitrelle (updated)
choriogonadotropin alfa, Anovulation; Reproductive Techniques, Assisted; Infertility, Female
Date of authorisation: 02/02/2001, Revision: 22, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Filgrastim Hexal (updated)
filgrastim, Neutropenia; Hematopoietic Stem Cell Transplantation; Cancer
Date of authorisation: 06/02/2009,, Revision: 23, Authorised, Last updated: 04/10/2023
-
List item
Human medicine European public assessment report (EPAR): CellCept (updated)
mycophenolate mofetil, Graft Rejection
Date of authorisation: 14/02/1996, Revision: 38, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Lixiana (updated)
edoxaban tosilate, Stroke; Venous Thromboembolism
Date of authorisation: 19/06/2015, Revision: 18, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Riltrava Aerosphere (updated)
Budesonide, formoterol fumarate dihydrate, Glycopyrronium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 06/01/2022, Revision: 2, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Roteas (updated)
edoxaban tosilate, Stroke; Venous Thromboembolism
Date of authorisation: 19/04/2017, Revision: 11, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Rekovelle (updated)
follitropin delta, Anovulation
Date of authorisation: 12/12/2016, Revision: 6, Authorised, Last updated: 04/10/2023 -
List item
Human medicine European public assessment report (EPAR): Adynovi (updated)
rurioctocog alfa pegol, Hemophilia A
Date of authorisation: 08/01/2018,, Revision: 10, Authorised, Last updated: 03/10/2023
-
List item
Human medicine European public assessment report (EPAR): Yesafili (updated)
aflibercept, Macular Edema; Retinal Vein Occlusion; Diabetic Retinopathy; Myopia, Degenerative; Diabetes Complications
Date of authorisation: 15/09/2023,, , Authorised, Last updated: 03/10/2023
-
List item
Human medicine European public assessment report (EPAR): Foclivia (updated)
influenza virus surface antigens, inactivated: A/Viet Nam/1194/2004 (H5N1), Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 18/10/2009,
, Revision: 13, Authorised, Last updated: 03/10/2023
-
List item
Human medicine European public assessment report (EPAR): Tevimbra (updated)
Tislelizumab, Esophageal Squamous Cell Carcinoma
Date of authorisation: 15/09/2023,, , Authorised, Last updated: 02/10/2023
-
List item
Human medicine European public assessment report (EPAR): Tyenne (updated)
tocilizumab, Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis
Date of authorisation: 15/09/2023,, Authorised, Last updated: 02/10/2023
-
List item
Human medicine European public assessment report (EPAR): Adtralza (updated)
Tralokinumab, Dermatitis, Atopic
Date of authorisation: 17/06/2021,, Revision: 3, Authorised, Last updated: 02/10/2023
-
List item
Human medicine European public assessment report (EPAR): Brukinsa (updated)
zanubrutinib, Waldenstrom Macroglobulinemia
Date of authorisation: 22/11/2021,, Revision: 7, Authorised, Last updated: 29/09/2023
-
List item
Human medicine European public assessment report (EPAR): Locametz (updated)
gozetotide, Radionuclide Imaging
Date of authorisation: 09/12/2022, Revision: 2, Authorised, Last updated: 29/09/2023 -
List item
Human medicine European public assessment report (EPAR): Docetaxel Kabi (updated)
docetaxel, Head and Neck Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Prostatic Neoplasms; Breast Neoplasms
Date of authorisation: 22/05/2012,
, Revision: 15, Authorised, Last updated: 29/09/2023
-
List item
Human medicine European public assessment report (EPAR): Exforge HCT (updated)
valsartan, hydrochlorothiazide, Amlodipine besilate, Hypertension
Date of authorisation: 15/10/2009, Revision: 24, Authorised, Last updated: 29/09/2023